Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Moxafrica
Street 1: 103 Chestnut Rd
Street 2:
City: Oldbury
Post Code: B68 0AY
Country: United Kingdom of Great Britain and Northern Ireland
Phone: +44 121 4213480
Web Site:

Focal Point Contact Information

Salutation: Mr
First Name: Merlin
Last Name: Young
Title: Chair and Co-founder
Phone: +44 121 4213480

Alternate Focal Point Contact Information

Salutation: Mrs
First Name: Jenny
Last Name: Craig
Title: Co-founder and secretary

General Information

Board Constituency: Developed Country NGO
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Moxafrica is a UK registered charity active in the systematic investigation of a traditional Japanese treatment that was used and reserached in the early part of the 20th century for treating tuberculosis. This is moxibustion, specifically 'small cone direct moxibustion'. The aims specifically orientate themselves aroudn the threat of drug-resistant TB.
Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 0
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 6 - 10
What is your organization's annual budget (USD) dedicated to TB? $10,001-$25,000
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are noty actively interested in our own NTP. The treatment we are investigating is specifically appropraite to resource-poor environments (which the UK is not).

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
South Africa


Research and Development

Specializations in Countries

Research and Development South Africa
Research and Development Uganda


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
With the benefit of results from existing research using small cone direct moxa as an adjunctive treatment for DS-TB cases in a phase II RCT we are keen to develop similar studies specifically focusing on responses in diagnosed DR-TB patients.

We are intent on depeening our understanding of how the treatment we are investigating may benefit co-infected patients.

Our fundamental interest is in seeing whether our investigations may help rates of successful treatment and cure in MDR- and XDR-TB patients.


Declaration of interests:

Application date: September 9, 2015
Last updated: October 9, 2015